Showing results (1-10 of 190) with videos related to
Sort By:
Pageof 19
Leukemia|April 17, 2012
Standardized definitions of molecular response in chronic myeloid leukemiaN C P Cross, H E White, M C Müller, et al.Leukemia|September 23, 2006
Rationale for the recommendations for harmonizing current methodology for detecting BCR-ABL transcripts in patients with chronic myeloid leukaemiaS Branford, N C P Cross, A Hochhaus, et al.Leukemia|August 28, 2009
Harmonization of molecular monitoring of CML therapy in EuropeM C Müller, N C P Cross, P Erben, et al.Leukemia|July 3, 2002
Tyrosine kinase fusion genes in chronic myeloproliferative diseasesN C P Cross, A ReiterLeukemia|April 1, 2005
The t(8;17)(p11;q23) in the 8p11 myeloproliferative syndrome fuses MYO18A to FGFR1C Walz, A Chase, C Schoch, et al.Leukemia|June 20, 2017
Molecular characterization of EZH2 mutant patients with myelodysplastic/myeloproliferative neoplasmsJ Rinke, J P Müller, M F Blaess, et al.Cellular and Molecular Life Sciences : CMLS|December 8, 2004
Oncogenic derivatives of platelet-derived growth factor receptorsA V Jones, N C P CrossActa Haematologica|March 29, 2002
The 8p11 myeloproliferative syndrome: a distinct clinical entity caused by constitutive activation of FGFR1D Macdonald, A Reiter, N C P CrossBest Practice & Research. Clinical Haematology|June 20, 2006
Eosinophilic disorders: molecular pathogenesis, new classification, and modern therapyJason Gotlib, N C P Cross, D Gary GillilandPageof 19